Clostridium difficile-associated colitis. Part 2: Therapy and prevention

被引:0
|
作者
Markus, P. M. [1 ]
机构
[1] Elisabeth Krankenhaus Essen Contilia GmbH, Akad Lehrkrankenhaus, Klin Allgemein Viszeral & Unfallchirurg, Klara Kopp Weg 1, D-45138 Essen, Germany
关键词
Pseudomembranous colitis; Clostridium difficile toxin A; Clostridium difficile toxin B Metronidazole; Vancomycin;
D O I
10.1007/s00053-012-0316-2
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Clostridium difficile is an anaerobic, Gram positive, spore-forming and toxin-producing bacillus. Colonization of the intestinal tract is facilitated by the administration of various antibiotics, in particular clindamycin, broad spectrum penicillins, fluorochinlones and cephalosporins. The clinical manifestations of C. difficile infections range from an asymptomatic carrier to fulminant disease with toxic megacolon. The cardinal clinical symptom is watery diarrhea accompanied by a pronounced leucocytosis. The most important initial step in the treatment of C. difficile - associated colitis is cessation of the responsible antibiotic. Treatment of non-severe C. difficile infection consists of oral metronidazole and patients with severe C. difficile - associated colitis are treated with oral vancomycin. The recurrence rate is high and a distinction must be made between a true reinfection with a different strain and a relapse of persistent diarrhea.
引用
收藏
页码:447 / 453
页数:7
相关论文
共 50 条
  • [41] Cytomegalovirus Colitis: A Mimicker and a Predisposing Factor of Clostridium difficile-Associated Diarrhea
    Mekaroonkamol, Parit
    Yun, Jeong H.
    Mekaroonkamol, Pojnicha
    Share, Michael
    Silverman, Michael
    GASTROENTEROLOGY, 2012, 142 (05) : S130 - S130
  • [42] Predicting Post-Operative Mortality for Clostridium difficile-Associated Colitis
    Alavi, Karim
    Servin, Jose Andres Cervera
    Sturrock, Paul
    Sweeney, W. B.
    Tseng, Jennifer F.
    Maykel, Justin A.
    GASTROENTEROLOGY, 2010, 138 (05) : S884 - S884
  • [43] PREDICTORS OF FAILURE WITH FECAL MICROBIOTA THERAPY FOR RECURRENT CLOSTRIDIUM DIFFICILE COLITIS.
    True, E.
    Tsoraides, S.
    Wang, H.
    Farrell, J.
    Bonello, J.
    DISEASES OF THE COLON & RECTUM, 2014, 57 (05) : E99 - E100
  • [44] Clostridium difficile-associated colitis (vol 50, pg 1536, 2004)
    Hull, M
    Beck, P
    CANADIAN FAMILY PHYSICIAN, 2005, 51 : 189 - 190
  • [45] Severe Clostridium difficile-associated colitis in young patients with cystic fibrosis
    Rivlin, J
    Lerner, A
    Augarten, A
    Wilschanski, M
    Kerem, E
    Ephros, MA
    JOURNAL OF PEDIATRICS, 1998, 132 (01): : 177 - 179
  • [46] Fecal Transplantation An Option for refractory Chronic Clostridium difficile-associated Colitis
    Menzel, J.
    GASTROENTEROLOGE, 2013, 8 (04): : 336 - 337
  • [47] Clostridium difficile-associated diarrhea in the elderly
    Brandt, LJ
    Kosche, KA
    Greenwald, DA
    Berkman, D
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1999, 94 (11): : 3263 - 3266
  • [48] Efficacy of fecal therapy for recurrent Clostridium difficile-associated diarrhea
    Keller, J. J.
    Nieuwdorp, M.
    van Heukelem, H.
    Visser, C.
    Kuijper, E. J.
    Speelman, R.
    Bartelsman, J. F. W. M.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2008, 20 (07) : A54 - A54
  • [49] Chilean consensus of prevention, diagnosis and treatment of Clostridium difficile-associated diarrhea
    Hernandez-Rocha, Cristian
    Pidal, Paola
    Cristina Ajenjo, M.
    Quera, Rodrigo
    Quintanilla, Marcela
    Lubascher, Jaime
    Irene Jemenao, M.
    Ibanez, Patricio
    Alvarez-Lobos, Manuel
    Diomedi, Alexis
    Marcotti, Alejandra
    Acuna, Mirta
    Arab, Juan P.
    Riquelme, Arnoldo
    Candia, Roberto
    Carvajal, Sergio
    REVISTA CHILENA DE INFECTOLOGIA, 2016, 33 (01): : 99 - 118
  • [50] Epidemiology of Clostridium difficile-associated infections
    Barbut, F
    Petit, JC
    CLINICAL MICROBIOLOGY AND INFECTION, 2001, 7 (08) : 405 - 410